Inovio Pharmaceuticals, Inc. (INO)
1.125
0.00 (0.00%)
USD |
NASDAQ |
Apr 06, 15:34
Inovio Pharmaceuticals SG&A Expense (TTM) : 32.68M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| ADMA Biologics, Inc. | 96.42M |
| Vaxart, Inc. | 17.61M |
| Capricor Therapeutics, Inc. | 23.69M |
| Allogene Therapeutics, Inc. | 56.78M |